Paragraph 132 I1
United Kingdom
In regulation 165 (omission of regulation 204 (obligation on licensing authority in relation to public announcements))—
(a)
in the heading for “Omission” substitute “ Amendment ”;
(b)
for “Omit” substitute “ In ”;
(c)
after “regulation 204” insert “, in paragraph (1), after “ pharmacovigilance concerns ” insert “ which relate to products authorised under a UKMA(NI) or UKMA(UK) ”.
Annotations
Commencement
- I1
Sch. 2 para. 132 in force at 31.12.2020 immediately before IP completion day, see reg. 1